SEC Form D private-offering filing

Dermata Therapeutics, Inc.

Name: Dermata Therapeutics, Inc. - new SEC Form D private-offering filing, San Diego, CA
Published: 2026-01-07

A new SEC Form D private-offering notice from San Diego, CA, a $4,124,591 filer-stated offering target in Biotech. The source filing is one click away.

Dermata Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical-stage biotechnology company (Nasdaq: DRMA) developing topical treatments for skin conditions like acne, psoriasis, and rosacea using its Spongilla technology platform.

Filed 2026-01-07Filed to raise $4,124,591First money in 2025-12-29Raised so far $4,124,591HQ (as filed) San Diego, CASector Biotech ✓Stage (inferred) SeedCall status Needs classification

Source linked the Form D on EDGAR↗Website verified dermatarx.com↗Named in the filing 11 executives & directors

Open this row on the live feed →More new filings in California →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.